Our study suggests that SP-D, KL-6, and CC16 are believed be potential biomarkers aiding the PaO2/FiO2 ratio in ARDS’ clinical identification and mortality prediction. The gene discussed is SCGB1A1; the disease is acute respiratory distress syndrome.